| Financial Year |
March 31 2023 |
| Monetary Funds |
2,778,024,813.84 |
| Held-for-trading Financial Assets |
205,841,095.89 |
| Notes Receivable |
11,039,119.20 |
| Accounts Receivable |
1,888,911,743.72 |
| Advances to Suppliers |
5,019,135,300.66 |
| Other Receivables |
488,381,381.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,367,614,453.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,429,870,265.76 |
| Total Current Assets |
29,787,189,183.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
177,421,768.13 |
| Investment Properties |
-- |
| Fixed Assetes |
14,840,311,477.88 |
| Under-construction Projects |
1,333,062,418.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
942,596,649.96 |
| R&D expenses |
-- |
| Goodwill |
8,250,639.90 |
| Long-Term Deferred and Prepaid Expenses |
10,525,228.06 |
| Deferred Income Tax Assets |
112,319,290.54 |
| Other Non-Current Assets |
271,140,822.17 |
| Sub-Total of Non-Current Assets |
24,772,644,676.30 |
| Total Assets |
54,559,833,859.40 |
| Short-Term Loans |
2,578,941,072.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,837,721,613.73 |
| Accounts Payable |
6,272,537,404.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
573,848,185.56 |
| Taxes Payable |
152,001,154.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,367,365,039.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
185,877,760.57 |
| Other Current Liabilities |
511,482,587.63 |
| Sub-Total of Current Liabilities |
26,688,654,478.82 |
| Long-term Loans |
470,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
70,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
7,155,435.97 |
| Deferred Income Tax Liabilities |
10,350,057.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
759,255,459.26 |
| Total Liabilities |
27,447,909,938.08 |
| Paid-In Capital(Or Share Stock) |
3,188,722,696.00 |
| Capital Surplus |
5,481,426,841.20 |
| Surplus Reserve |
2,210,097,157.60 |
| LESS:Treasury Stock |
261,453,536.66 |
| Undistributed Profits |
15,735,018,434.89 |
| Minority Stockholder's Interest |
722,220,582.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
26,389,703,338.42 |
| Owner's Equity（Stockholder's Equity） |
27,111,923,921.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
54,559,833,859.40 |
